Anlon Healthcare IPO subscription status reached 1.69 times on the first day. The retail portion was subscribed to 8.99 times, while the non-institutional investment segment received 71% of the bid, and the qualified institutional buyers segment attracted 91% of the bid. The entry window for the initial public offering of Anlon Healthcare (IPO) is planned to open on Tuesday, August 26, and will close on Friday 29 August. Anlon Healthcare IPO price band has been determined to be between £ 86 and £ 91 a share, which has a face value of £ 10. 75% of the shares in the Anlon Healthcare IPO are allocated to qualified institutional buyers (QIB), while no more than 15% for non-institutional investors (NII) will be named, and up to 10% for retail investors. The granting of shares for the IPO of the Anlon Healthcare is expected to be completed on Monday, September. Refunds start on Tuesday, September 2, and shares are credited to the Demat accounts of the Allottese on the same day. Anlon Healthcare IPO GMP is +5 today. This indicates that the share price of Anlon Healthcare traded at a £ 5 premium in the Gray market, according to Investorgain.com. Taking into account the top of the IPO price band and the current premium in the Gray market, the estimated list price of the Anlon Healthcare share price is indicated at £ 96, which is 5.49% higher than the £ 91 IPO price over the past eight sessions, the IPO GMP is expected to be upwards and The minimum GMP recorded is £ 0.00, while the maximum GMP is £ 5, as indicated by experts. ‘Gray Market Premium’ indicates investors’ readiness to pay more than the issue price. Anlon Healthcare IPO Review Anand Rathi Research indicates that the sector in which the company operates has substantial obstacles to enter and out, mainly due to protracted customer approval processes and strict standards for compliance with regulations. With an EV/ebitda of 16.7x and a market cap of £ 4.836m after issuing shares, the company is valued at a p/e of 19.0x based on its FY25 earnings at the maximum price range. The broker sets a ‘sign on a long -term’ rating for the IPO, and believes it is appropriately valued. Anlon Healthcare IPO Details Anlon Healthcare IPO involves a new release of 1.33 crore shares. If the shares are sold at the highest price in the range, the total value of the offer is about £ 121. The funds raised from this issue will be used for the expansion of the company’s manufacturing facility (£ 30.7 crore), the improvement of working capital (£ 43.15 crore), the repayment of debt and the support of different corporate projects. Interactive Financial Services acts as the only book manager for this offer. Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, and not of currency. We advise investors to check with certified experts before making investment decisions.
Anlon Healthcare IPO Day 2 Live: Check GMP, subscription status, review, more. Apply or not?
